15.04.04.2696.Clin.05.00.0.181231

1. CMS2v7: Preventive Care and Screening: Screening for
Depression and Follow-Up Plan

2. CMS22v6: Preventive Care and Screening: Screening for
High Blood Pressure and Follow-Up Documented

3. CMS50v6: Closing the Referral Loop: Receipt of
Specialist Report

4. CMS52v6: HIV/AIDS:
Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis

5. CMS56v6:
Functional Status Assessment for Total Hip Replacement

6. CMS65v7:
Hypertension: Improvement in Blood Pressure

7. CMS66v6:
Functional Status Assessment for Total Knee Replacement

8. CMS68v7:
Documentation of Current Medications in the Medical Record

9. CMS69v6:
Preventive Care and Screening: Body Mass Index (BMI)
Screening and Follow-Up Plan

10. CMS74v7:
Primary Caries Prevention Intervention as Offered by
Primary Care Providers, including Dentists

11. CMS75v6: Children Who Have Dental Decay or Cavities

12. CMS82v5: Maternal Depression Screening

13. CMS90v7:
Functional Status Assessments for Congestive Heart Failure

14. CMS117v6: Childhood Immunization Status

15. CMS122v6: Diabetes: Hemoglobin A1c (HbA1c)
Poor Control (> 9%)

16. CMS123v6: Diabetes: Foot Exam

17. CMS124v6: Cervical Cancer Screening

18. CMS125v6: Breast Cancer Screening

19. CMS127v6: Pneumococcal Vaccination Status
for Older Adults

20. CMS128v6: Anti-depressant Medication Management

21. CMS129v7: Prostate Cancer: Avoidance of Overuse of
Bone Scan for Staging Low Risk Prostate Cancer Patients

22. CMS130v6: Colorectal Cancer Screening

23. CMS131v6: Diabetes: Eye Exam

24. CMS132v6: Cataracts: Complications within 30 Days
Following Cataract Surgery Requiring Additional Surgical
Procedures

25. CMS133v6: Cataracts: 20/40 or Better Visual
Acuity within 90 Days Following Cataract Surgery

26. CMS134v6: Diabetes: Medical Attention for Nephropathy

27. CMS135v6: Heart Failure (HF):
Angiotensin-Converting Enzyme (ACE) Inhibitor or
Angiotensin Receptor Blocker (ARB) Therapy
for Left Ventricular Systolic Dysfunction (LVSD)

28. CMS136v7: Follow-Up Care for Children
Prescribed ADHD Medication (ADD)

29. CMS137v6: Initiation and Engagement of
Alcohol and Other Drug Dependence Treatment

30. CMS138v6: Preventive Care and Screening:
Tobacco Use: Screening and Cessation Intervention

31. CMS139v6: Falls: Screening for Future Fall Risk

32. CMS142v6: Diabetic Retinopathy: Communication
with the Physician Managing Ongoing Diabetes Care

33. CMS143v6: Primary Open-Angle Glaucoma (POAG):
Optic Nerve Evaluation

34. CMS144v6: Heart Failure (HF): Beta-Blocker Therapy
for Left Ventricular Systolic Dysfunction (LVSD)

35. CMS145v6: Coronary Artery Disease (CAD):
Beta-Blocker Therapy-Prior Myocardial Infarction (MI)
or Left Ventricular Systolic Dysfunction (LVEF <40%)

36. CMS146v6: Appropriate Testing for
Children with Pharyngitis

37. CMS147v7: Preventive Care and Screening:
Influenza Immunization

38. CMS149v6: Dementia: Cognitive Assessment

39. CMS153v6: Chlamydia Screening for Women

40. CMS154v6: Appropriate Treatment for
Children with Upper Respiratory Infection (URI)

41. CMS155v6: Weight Assessment and Counseling for
Nutrition and Physical Activity for Children and Adolescents

42. CMS156v6: Use of High-Risk Medications in the Elderly

43. CMS157v6: Oncology: Medical and
Radiation - Pain Intensity Quantified

44. CMS158v6: Pregnant women that had HBsAg testing

45. CMS159v6: Depression Remission at Twelve Months

46. CMS160v6: Depression Utilization of the PHQ-9 Tool

47. CMS161v6: Adult Major Depressive
Disorder (MDD): Suicide Risk Assessment

48. CMS164v6: Ischemic Vascular Disease (IVD):
Use of Aspirin or Another Antithrombotic

49. CMS165v6: Controlling High Blood Pressure

50. CMS167v6: Diabetic Retinopathy:
Documentation of Presence or Absence of
Macular Edema and Level of Severity of Retinopathy

51. CMS169v6: Bipolar Disorder and Major Depression:
Appraisal for alcohol or chemical substance use

52. CMS177v6: Child and Adolescent Major
Depressive Disorder (MDD): Suicide Risk Assessment

53. CMS347v1: Statin Therapy for the Prevention
and Treatment of Cardiovascular Disease

54. CMS645v1: Bone density evaluation for patients
with prostate cancer and receiving androgen
deprivation therapy

This Health IT Module is compliant with the ONC
Certification Criteria for Health IT and has been
certified by an ONC-ACB in accordance with the
applicable certification criteria adopted by the
Secretary of Health and Human Services.
This certification does not represent an endorsement
by the U.S. Department of Health and Human Services.

There are no technical or practical considerations
associated with this service.